Quantifying the sensitivities of EGF receptor (EGFR) tyrosine kinase inhibitors in drug resistant non-small cell lung cancer (NSCLC) cells using hydrogel-based peptide array.

Quantifying the sensitivities of EGF receptor (EGFR) tyrosine kinase inhibitors in drug resistant non-small cell lung cancer (NSCLC) cells using hydrogel-based peptide array. Biosens Bioelectron. 2010 Oct 15; 26(2):424-31.

View in: PubMed

subject areas

Antineoplastic Agents
Carcinoma, Non-Small-Cell Lung
Drug Resistance, Neoplasm
Drug Screening Assays, Antitumor
Equipment Design
Equipment Failure Analysis
ErbB Receptors
Erlotinib Hydrochloride
Humans
Hydrogels
Lung Neoplasms
Peptides
Protein Array Analysis
Protein-Tyrosine Kinases
Quinazolines

authors with profiles

Stephen J. Kron